TEVA – teva pharmaceutical industries limited american depositary shares (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

TEVA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/19

12:07 pm

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/19

12:07 pm

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/19

12:07 pm

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/16

11:07 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/10

07:18 am

teva

Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.

Low Report

Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.

Report

12/9

11:22 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/9

11:22 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/9

09:06 am

teva

Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $35.00 price target on the stock.

Low Report

Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $35.00 price target on the stock.

Report

12/8

04:27 pm

teva

Teva initiated with an Overweight at Barclays

Low Report

Teva initiated with an Overweight at Barclays

Report

12/8

04:27 pm

teva

Teva initiated with an Overweight at Barclays

Low Report

Teva initiated with an Overweight at Barclays

Report

12/8

11:33 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/8

11:33 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/8

11:33 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/5

09:58 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/5

09:58 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

12/5

09:11 am

teva

Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.

Low Report

Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.

Report

12/5

09:11 am

teva

Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.

Low Report

Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.

Report

12/4

04:18 pm

teva

Teva initiated with an Outperform at Scotiabank

Low Report

Teva initiated with an Outperform at Scotiabank

Report

12/4

04:18 pm

teva

Teva initiated with an Outperform at Scotiabank

Low Report

Teva initiated with an Outperform at Scotiabank

Report

11/6

05:03 pm

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

10/3

08:19 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

9/24

08:53 am

teva

Rating for TEVA

Low Report

Rating for TEVA

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.